The current financial score of cbdMD Inc is 7.96. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.55M, representing a year-over-year increase of 20.56%, while its net profit experienced a year-over-year increase of 2.49%.
The current valuation score of cbdMD Inc is 8.64. Its current P/E ratio is 0.02, which is 9232.58% below the recent high of 1.66 and 20730.34% above the recent low of -3.67.
The current earnings forecast score of cbdMD Inc is 6.00. The average price target is 2.00, with a high of 2.00 and a low of 2.00.
The current price momentum score of cbdMD Inc is 4.05. Currently, the stock price is trading between the resistance level at 0.54 and the support level at 0.46, making it suitable for range-bound swing trading.
The current institutional shareholding score of cbdMD Inc is 3.00. The latest institutional shareholding proportion is 5.38%, representing a quarter-over-quarter decrease of 47.09%.
The current risk assessment score of cbdMD Inc is 2.44. The company's beta value is 2.15. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.